Nagao T, Ohshimo T, Mitsunobu K, Sato M, Otsuki S
Biol Psychiatry. 1979 Jun;14(3):509-23.
Lumbar CSF HVA, MHPG, 5HIAA, cAMP, and cGMP were measured in 12 chronic schizophrenics with tardive dyskinesia before and 3 weeks after sodium valproate (VPA) or cyproheptadine treatment. HVA levels significantly decreased and cAMP and cGMP levels significantly increased during the administration of VPA or cyproheptadine. There were no significant correlations between the degree of improvement in tardive dyskinesia and the changes of amine metabolities or cyclic nucleotides. None of the pretreatment values for CSF amine metabolites or cyclic nucleotides were different from those of 15 chronic schizophrenics without tardive dyskinesia as controls. Decrease of HVA and increase of cGMP during the treatment might indicate the normalization of dopaminergic-cholinergic imbalance in the brain. Furthermore, significantly low levels of 5HIAA were observed in the patients with drug-induced tremor. It is suggested that neuroleptic-induced tremor may be attributed to serotonergic dysfunction in the brain.
对12例患有迟发性运动障碍的慢性精神分裂症患者在服用丙戊酸钠(VPA)或赛庚啶治疗前及治疗3周后测定其腰椎脑脊液中的高香草酸(HVA)、3-甲氧基-4-羟基苯乙二醇(MHPG)、5-羟吲哚乙酸(5HIAA)、环磷酸腺苷(cAMP)和环磷酸鸟苷(cGMP)。在服用VPA或赛庚啶期间,HVA水平显著降低,cAMP和cGMP水平显著升高。迟发性运动障碍的改善程度与胺代谢产物或环核苷酸的变化之间无显著相关性。脑脊液胺代谢产物或环核苷酸的治疗前值与15例无迟发性运动障碍的慢性精神分裂症患者(作为对照)的数值无差异。治疗期间HVA的降低和cGMP的升高可能表明大脑中多巴胺能-胆碱能失衡的正常化。此外,在药物性震颤患者中观察到5HIAA水平显著降低。提示抗精神病药物所致震颤可能归因于大脑中的5-羟色胺能功能障碍。